Business Context and Reporting Period
Company: Community Health Systems, Inc. (CYH)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Three months ended March 31, 2026
Business Overview: A large healthcare provider operating 65 affiliated hospitals with over 9,000 beds across 13 states. The company operates a single reportable segment focused on hospital operations, including inpatient and outpatient services.
Key Financial Metrics
| Metric (in millions, except per share) | Q1 2026 | Q1 2025 |
|---|---|---|
| Net Operating Revenues | $2,965 | $3,159 |
| Income from Operations | $281 | $284 |
| Net (Loss) Income | $(25) | $25 |
| Net Loss Attributable to Stockholders | $(58) | $(13) |
| Loss Per Share (Diluted) | $(0.43) | $(0.10) |
| Operating Cash Flow | $(297) | $120 |
| Investing Cash Flow | $1,023 | $444 |
| Financing Cash Flow | $(274) | $(170) |
| Cash and Cash Equivalents (Ending) | $712 | $431 |
| Total Debt (Long-term + Current) | $10,156 | $10,396 |
| ABL Facility Availability | $824 | N/A |
Material Changes vs. Prior Period
- Revenue Decline: Net operating revenues decreased 6.1% to $2.965 billion, primarily due to the divestiture of hospitals in 2026 and 2025. On a same-store basis, revenues increased 3.1% driven by higher reimbursement rates, partially offset by lower volumes.
- Profitability Shift: The company reported a net loss of $25 million compared to net income of $25 million in the prior year. Net loss attributable to stockholders widened to $58 million from $13 million.
- Divestiture Activity: Significant asset sales occurred, including three hospitals in Pennsylvania and an 80% interest in a Tennessee hospital. These transactions generated a net gain of $90 million (including a $230 million gain on sale partially offset by $140 million in impairment charges).
- Cash Flow Volatility: Operating cash flow swung from a $120 million inflow in Q1 2025 to a $297 million outflow in Q1 2026, driven by increased patient accounts receivable and decreased accounts payable. Investing cash flow turned strongly positive ($1.023 billion) due to $1.108 billion in proceeds from hospital dispositions.
- Admissions: Consolidated inpatient admissions decreased 10.8% and adjusted admissions decreased 10.5% year-over-year. Same-store admissions decreased 1.3%.
Guidance, Outlook, and Risks
- Legislative Impact: Management highlights significant uncertainty regarding the "2025 Reconciliation Law," which is expected to decrease access to health insurance and reduce federal Medicaid spending. This may increase self-pay patients and adversely impact revenue.
- Regulatory Environment: Ongoing changes in HHS structure, potential Medicaid block grants, and Supreme Court decisions affecting agency authority create regulatory uncertainty. CMS payment rate reductions for non-drug services under the outpatient PPS are expected to continue impacting results.
- Capital Allocation: Proceeds from divestitures are expected to be used for general corporate purposes, including debt repayments and capital expenditures. The company expects total capital expenditures of $350 million to $400 million for 2026.
- Debt Management: The company redeemed $223 million of 10.875% Senior Secured Notes due 2032, incurring an $8 million loss on early extinguishment. Total debt remains high at approximately $10.2 billion, with $29 million due within 12 months.
- Legal Proceedings: The company is subject to various legal proceedings, including a DOJ investigation regarding a former medical director and a civil lawsuit regarding the 2016 spin-off of Quorum Health Corporation. Management does not currently believe these will have a material adverse effect.
Investor Verification Checklist
- Divestiture Proceeds: Verify the final working capital adjustments and net proceeds from the Crestwood Medical Center sale ($459 million preliminary) and the Arkansas hospital group sale ($112 million pending).
- Medicaid Exposure: Assess the specific impact of the 2025 Reconciliation Law on the seven states where the company operates that have expanded Medicaid versus the six that have not.
- Receivables Quality: Monitor Days Revenue Outstanding (59 days at March 31, 2026) and the composition of self-pay receivables, which represent 25.6% of gross receivables.
- Debt Covenants: Confirm compliance with the ABL Facility covenants, specifically the consolidated fixed charge coverage ratio, which is triggered if availability falls below $95 million.
- Impairment Risks: Review the carrying value of remaining goodwill ($3.1 billion) and long-lived assets, as future declines in stock price or operating results could trigger additional impairment charges.